首页> 外文OA文献 >Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease

【2h】

Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease

机译：一种用于治疗炎性肠病的新型，口服抗肿瘤坏死因子结构域抗体的临床前发展

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
J. Scott Crowe; Kevin J. Roberts; Timothy M. Carlton; Luana Maggiore; Marion F. Cubitt; Simon Clare; Katherine Harcourt; Jill Reckless; Thomas T. MacDonald; Keith P. Ray; Anna Vossenkämper; Michael R. West;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease [J] . J. Scott Crowe, Kevin J. Roberts, Timothy M. Carlton, Scientific reports. . 2018,第1期

机译：一种用于治疗炎性肠病的新型，口服抗肿瘤坏死因子结构域抗体的临床前发展
2. Anti-tumour necrosis factor-alpha antibodies and B cell homeostasis in human inflammatory bowel diseases [J] . Defendenti Caterina, Atzeni Fabiola, Malandrin Sergio, International immunopharmacology . 2018,第期

机译：抗肿瘤坏死因子-α抗体和人炎症肠疾病中的B细胞稳态
3. Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) [J] . Drugs and aging . 2020,第5期

机译：与患者炎症性肠疾病患者抗肿瘤坏死因子治疗的持久性与患者相比：来自炎症性肠疾病的西西里网络数据（SN-IBD）
4. T-cell modulating antibodies in inflammatory bowel disease [C] . D. C. BAUMGAR Falk Symposium . 2007

机译：T细胞调节炎症性肠病的抗体
5. Novel Distinct Roles for Intestinal/Macrophage Cyclooxygenase 2 and Apolipoprotein Mimetic Peptides in the Development and Treatment of Inflammatory Bowel Diseases [D] . Meriwether, David. 2018

机译：肠道/巨噬细胞环氧合酶2和载脂蛋白模拟肽在炎症性肠病的发生和治疗中的新型独特作用
6. Preclinical Development of a Novel Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease [O] . J. Scott Crowe, Kevin J. Roberts, Timothy M. Carlton, -1

机译：新型口服抗肿瘤坏死因子域抗体的临床前开发用于治疗炎性肠病
7. P299 Loss-of-response to anti-tumour necrosis factor-α critically depends on treatment duration in patients with Inflammatory Bowel Disease [O] . J Schultheiss, R Mahmoud, J Louwers, 2021

机译：P299对抗肿瘤坏死因子-α的反应丧失重点依赖性取决于炎症性肠病患者的治疗持续时间

相关主题

Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease

著录项

引文网络

相似文献

相关主题

期刊订阅